These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26896782)

  • 1. Evolution of rational vaccine designs for genital herpes immunotherapy.
    Kaufmann JK; Flechtner JB
    Curr Opin Virol; 2016 Apr; 17():80-86. PubMed ID: 26896782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
    Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
    Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenge of developing a herpes simplex virus 2 vaccine.
    Dropulic LK; Cohen JI
    Expert Rev Vaccines; 2012 Dec; 11(12):1429-40. PubMed ID: 23252387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection.
    Önnheim K; Ekblad M; Görander S; Bergström T; Liljeqvist JÅ
    Viruses; 2016 Apr; 8(4):110. PubMed ID: 27110813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses elicited by the GEN-003 candidate HSV-2 therapeutic vaccine in a randomized controlled dose-ranging phase 1/2a trial.
    Flechtner JB; Long D; Larson S; Clemens V; Baccari A; Kien L; Chan J; Skoberne M; Brudner M; Hetherington S
    Vaccine; 2016 Oct; 34(44):5314-5320. PubMed ID: 27642130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread.
    Awasthi S; Zumbrun EE; Si H; Wang F; Shaw CE; Cai M; Lubinski JM; Barrett SM; Balliet JW; Flynn JA; Casimiro DR; Bryan JT; Friedman HM
    J Virol; 2012 Apr; 86(8):4586-98. PubMed ID: 22318147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
    Fotouhi F; Soleimanjahi H; Roostaee MH; Behzadian F
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):18-26. PubMed ID: 18647350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
    Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P
    PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes.
    Bernstein DI; Cardin RD; Bravo FJ; Hamouda T; Pullum DA; Cohen G; Bitko V; Fattom A
    Vaccine; 2019 Oct; 37(43):6470-6477. PubMed ID: 31515143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology. Painful failure of promising genital herpes vaccine.
    Cohen J
    Science; 2010 Oct; 330(6002):304. PubMed ID: 20947733
    [No Abstract]   [Full Text] [Related]  

  • 11. A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.
    Chiuppesi F; Vannucci L; De Luca A; Lai M; Matteoli B; Freer G; Manservigi R; Ceccherini-Nelli L; Maggi F; Bendinelli M; Pistello M
    J Virol; 2012 Jun; 86(12):6563-74. PubMed ID: 22491465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
    Tengvall S; O'Hagan D; Harandi AM
    Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs.
    Hoshino Y; Dalai SK; Wang K; Pesnicak L; Lau TY; Knipe DM; Cohen JI; Straus SE
    J Virol; 2005 Jan; 79(1):410-8. PubMed ID: 15596834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intramuscular and footpad subcutaneous immunization with DNA vaccine encoding HSV-gD2 in mice.
    Jazayeri M; Soleimanjahi H; Fotouhi F; Pakravan N
    Comp Immunol Microbiol Infect Dis; 2009 Sep; 32(5):453-61. PubMed ID: 18571235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus type 2 vaccines: new ground for optimism?
    Aurelian L
    Clin Diagn Lab Immunol; 2004 May; 11(3):437-45. PubMed ID: 15138167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model.
    Awasthi S; Hook LM; Shaw CE; Friedman HM
    Hum Vaccin Immunother; 2017 Dec; 13(12):2785-2793. PubMed ID: 28481687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between herpes simplex virus neutralizing antibody titers determined by ELVIS cell and traditional plaque reduction assays.
    Blevins TP; Yu Y; Belshe RB; Bellamy AR; Morrison LA
    PLoS One; 2019; 14(4):e0214467. PubMed ID: 30946751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol improves genital herpes vaccine efficacy in mice.
    Pennock JW; Stegall R; Bell B; Vargas G; Motamedi M; Milligan G; Bourne N
    Vaccine; 2009 Sep; 27(42):5830-6. PubMed ID: 19660586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of recurrent HSV disease using imiquimod alone or combined with a glycoprotein vaccine.
    Harrison CJ; Miller RL; Bernstein DI
    Vaccine; 2001 Feb; 19(13-14):1820-6. PubMed ID: 11166907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.
    Skoberne M; Cardin R; Lee A; Kazimirova A; Zielinski V; Garvie D; Lundberg A; Larson S; Bravo FJ; Bernstein DI; Flechtner JB; Long D
    J Virol; 2013 Apr; 87(7):3930-42. PubMed ID: 23365421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.